(Q35821634)

English

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation

scientific article published in May 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation (English)

1 reference

Europe PubMed Central

10 August 2017

0 references

Anthony Swerdlow

object named as

A J Swerdlow

1

0 references

author name string

A J Douglas

2

1 reference

Europe PubMed Central

10 August 2017

G V Hudson

3

1 reference

Europe PubMed Central

10 August 2017

B V Hudson

4

1 reference

Europe PubMed Central

10 August 2017

M H Bennett

5

1 reference

Europe PubMed Central

10 August 2017

K A MacLennan

6

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

1 May 1992

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

304

1 reference

Europe PubMed Central

10 August 2017

1137-1143

1 reference

Europe PubMed Central

10 August 2017

6835

1 reference

Europe PubMed Central

10 August 2017

Second primary cancers following treatment of Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Cohort study analysis with a FORTRAN computer program.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Second acute leukemia and other malignancies following treatment for Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Solid cancer risk after treatment of Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Second malignancies and Hodgkin's disease--the Royal Marsden Hospital experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Leukemia following Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

ChlVPP combination chemotherapy for Hodgkin's disease: long-term results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Late complications of Hodgkin's disease management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. British National Lymphoma Investigation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Mortality among women first employed before 1930 in the U.S. radium dial-painting industry. A group ascertained from employment lists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Leukemia and other cancers following radiation treatment of pelvic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

27 July 2018

Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1882078

24 September 2018

Risk of second cancers after treatment for Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1392790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/1392790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality from cancer and all causes among British radiologists

1 reference

https://pubmed.ncbi.nlm.nih.gov/1392790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematologic neoplasia in patients treated for Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1392790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1392790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1392790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.304.6835.1137

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35821634&oldid=1712286702"